All Posts:mRNA vaccine

• Promising Phase III Melanoma Results Build on Research Conducted at Georgetown Lombardi

  A promising new approach to preventing high-risk melanoma from recurring after surgery has yielded positive results in a large clinical trial, building on earlier research that included investigators and patients at Georgetown University’s Lombardi Comprehensive Cancer Center.

  Category: Lombardi Stories Tags: cancer, clinical trials, melanoma, mRNA vaccine, research

• New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients

  A new study conducted by an international team of researchers, including clinical investigators at Georgetown University’s Lombardi Comprehensive Cancer Center, demonstrates that a personalized cancer mRNA vaccine combined with immunotherapy reduces recurrence and improves survival for people with advanced melanoma.

  Category: Lombardi Stories Tags: cancer, cancer research, clinical trials, immunotherapy, mRNA vaccine